South & Central America Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement, and Others) and Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others)

BMIRE00030562 | Pages: 68 | Pharmaceuticals | Jul 2024 | Type: Regional | Status: Published

The South & Central America sarcopenia treatment market was valued at US$ 189.59 million in 2022 and is expected to reach US$ 268.50 million by 2030; it is estimated to register a CAGR of 4.4% from 2022 to 2030.

Products in Clinical Trial Phases Fuel South & Central America Sarcopenia Treatment Market

A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:

Sarcopenia Drug Under Clinical Development

Company Name

Interventions

Conditions

Clinical Trial Stage

Abbott Nutrition

Medical Food with AN777

Oral Nutritional Formula

Malnutrition

Sarcopenia

PHASE3

Nutricia Research

Dietary Supplement: Bolus ONS A

Dietary Supplement: Bolus ONS B

Dietary Supplement: Bolus ONS C

Dietary Supplement: Bolus ONS D

Sarcopenia

PHASE1

Novartis Pharmaceuticals

Drug: Bimagrumab

Sarcopenia

PHASE2

McMaster University

Behavioural: Step Reduction

Sarcopenia

PHASE1

Metabolic Technologies Inc.

Dietary Supplement: Placebo

Drug: HMB Plus Vitamin D

Behavioural: Non-Exercise

Behavioural: Exercise

Sarcopenia

PHASE1

Merck Sharp & Dohme LLC

Drug: Comparator MK-077

Drug: Comparator Placebo

Sarcopenia

PHASE2

Immunotec Inc.

Dietary Supplement: Immunocal

Dietary Supplement: Casein

Aging and Sarcopenia

PHASE2

Lijun Yang

Combination Product: 3-Month Intensive Intervention

Sarcopenia

PHASE4

Regeneron Pharmaceuticals

Drug: REGN1033 (SAR391786)

Drug: Placebo

Sarcopenia

PHASE2

Source: Company Websites and The Insight Partners Analysis

Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.

South & Central America Overview

The sarcopenia treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. A rise in the geriatric population and the surging incidence of vitamin Deficiency fuels the sarcopenia treatment market in South & Central America.

The introduction of new regulations by the National Sanitary Surveillance Agency (ANVISA) for dietary supplements in 2018 made the entry of new brands easier in Brazil. Moreover, it helped existing brands to flourish and innovate in the country. According to a study published in the National Library of Medicine, the elderly population is rapidly growing in Brazil, resulting in an increased prevalence of chronic conditions associated with old age. The overall prevalence of sarcopenia in the elderly population in Brazil was ~20.0% in 2020. According to an article published by National Institute of Health, in 2022, the prevalence of probable sarcopenia is 42.0% in older Brazilian women.

South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report :

South & Central America Segmentation

The South & Central America is categorized into treatment type, distribution channel, and country.

Based on treatment type, the South & Central America sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest South & Central America sarcopenia treatment market share in 2022.

In terms of distribution channel, the South & Central America sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest South & Central America sarcopenia treatment market share in 2022.

By country, the South & Central America sarcopenia treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America sarcopenia treatment market share in 2022.

Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the South & Central America sarcopenia treatment market.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics

4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics

4.2 Market Drivers

4.2.1 Upsurge in Geriatric Population

4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults

4.3 Key Market Restraints:

4.3.1 Unavailability of Direct Interventions

4.4 Key Market Opportunities:

4.4.1 Products in Clinical Trial Phases

4.5 Future Trends:

4.5.1 Rising Awareness About Sarcopenia

4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - South & Central America Market Analysis

5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030

5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis

6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type

6.1 Vitamin D and Calcium Supplement

6.1.1 Overview

6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.2 Protein Supplement

6.2.1 Overview

6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.3 Vitamin B12 Supplement

6.3.1 Overview

6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel

7.1 Pharmacies

7.1.1 Overview

7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

7.2 Retail Channels

7.2.1 Overview

7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.3 Online Channels

7.3.1 Overview

7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Sarcopenia Treatment Market - Country Analysis

8.1 South & Central America

8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country

8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel

8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)

8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type

8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

9.1 Overview

9.2 Growth Strategies in the Sarcopenia Treatment Market

9.3 Inorganic Growth Strategies

9.3.1 Overview

9.4 Organic Growth Strategies

9.4.1 Overview

10. Company Profiles

10.1 Abbott Laboratories

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Products and Services

10.1.4 Financial Overview

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 Bayer AG

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Products and Services

10.2.4 Financial Overview

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 Nestle Health Science SA

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Products and Services

10.3.4 Financial Overview

10.3.5 SWOT Analysis

10.3.6 Key Developments

10.4 Novartis AG

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Products and Services

10.4.4 Financial Overview

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 Pfizer Inc

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Products and Services

10.5.4 Financial Overview

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 Sanofi SA

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Products and Services

10.6.4 Financial Overview

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 Amway Corp

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Products and Services

10.7.4 Financial Overview

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 GSK Plc

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Products and Services

10.8.4 Financial Overview

10.8.5 SWOT Analysis

10.8.6 Key Developments

11. Appendix

11.1 About The Insight Partners

11.2 Glossary of Terms

List of Tables

Table 1. South & Central America Sarcopenia Treatment Market Segmentation

Table 2. Sarcopenia Drug Under Clinical Development

Table 3. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)

Table 4. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type

Table 5. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel

Table 6. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country

Table 7. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 8. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 9. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 10. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 11. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type

Table 12. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel

Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market

Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market

Table 15. Glossary of Terms, Sarcopenia Treatment Market

List of Figures

Figure 1. South & Central America Sarcopenia Treatment Market Segmentation, By Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030

Figure 4. South & Central America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030

Figure 5. Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 6. Protein Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 7. Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 8. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 9. South & Central America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030

Figure 10. Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 11. Retail Channels: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 12. Online Channels : South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 13. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)

Figure 14. South & Central America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)

Figure 15. South & Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)

Figure 16. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 17. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 18. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)

Figure 19. Growth Strategies in the Sarcopenia Treatment Market

1. Abbott Laboratories 
2. Bayer AG 
3. Nestle Health Science SA 
4. Novartis AG 
5. Pfizer Inc 
6. Sanofi SA 
7. Amway Corp
8. GSK Plc 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America sarcopenia treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America sarcopenia treatment market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440